Loading...
ARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatin
In ovarian clear cell carcinoma (OCCC), the mutation rate of the AT-rich interaction domain 1A (ARID1A) gene is 46–57%. However, the effects of ARID1A gene silencing by small interfering RNA (siRNA) on the sensitivity of OCCC to cisplatin have not been investigated. Thus, this study aimed to elucida...
Na minha lista:
| Udgivet i: | Exp Ther Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228580/ https://ncbi.nlm.nih.gov/pubmed/28105136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3863 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|